FemHealth Ventures is a seed to Series B venture capital firm deploying capital across drugs, devices, diagnostics, and digital applications in women's health. They invest against a proprietary framework that classifies conditions as affecting only women, mostly women, or differently in women, expanding the definition of the category well beyond reproductive health. The firm differentiates itself through authorship of the FemHealth Framework, first published in 2019 and since widely adopted across the industry as a standard segmentation model.